vindesine has been researched along with Cancer, Second Primary in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angrilli, F; Baldini, L; Cascavilla, N; Federico, M; Ferrari, A; Galimberti, S; Gobbi, PG; Ilariucci, F; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Musso, M; Polimeno, G; Scalzulli, PR; Stelitano, C | 1 |
| André, M; Bosly, A; Brice, P; Coiffier, B; Gaulard, P; Gisselbrecht, C; Haioun, C; Henry-Amar, M; Leleu, X; Morel, P; Mounier, N; Reyes, F; Sonet, A; Tilly, H | 1 |
| Broglia, C; Cavanna, L; Chisesi, T; Corazza, GR; Corbella, F; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Levis, A; Molica, S; Pavone, V; Sacchi, S; Valentino, F | 1 |
| Kobayashi, K; Matano, S; Matsuda, T; Misaki, T; Nakamura, S; Sugimoto, T | 1 |
| André, M; Brice, P; Cazals, D; Fermé, C; Gisselbrecht, C; Hennequin, C; Kerneis, Y; Lepage, E; Rousselot, P; Zini, JM | 1 |
| Hasegawa, Y; Itoh, T; Kojima, H; Komeno, T; Mori, N; Nagasawa, T; Ninomiya, H; Tamagawa, Y; Yatabe, Y | 1 |
| DeAngelis, LM; Olson, JD; Riedel, E | 1 |
| Doi, O; Higashiyama, M; Kodama, K; Koyama, H; Noguchi, S; Yokouchi, H | 1 |
3 trial(s) available for vindesine and Cancer, Second Primary
| Article | Year |
|---|---|
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Italy; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2016 |
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Epirubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Pilot Projects; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2006 |
Results of three courses of adriamycin, bleomycin, vindesine, and dacarbazine with subtotal nodal irradiation in 189 patients with nodal Hodgkin's disease (stage I, II and IIIA).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Gonads; Heart; Hodgkin Disease; Humans; Lung; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prospective Studies; Radiotherapy; Survival Rate; Thyroid Gland; Treatment Outcome; Vinblastine; Vindesine | 1997 |
5 other study(ies) available for vindesine and Cancer, Second Primary
| Article | Year |
|---|---|
Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cohort Studies; Cyclophosphamide; Doxorubicin; Female; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Retrospective Studies; Risk Factors; Vindesine | 2004 |
Decreased lymphocytic proliferation by mitogens in patients with transitional cell carcinoma of the renal pelvis subsequent to non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Transitional Cell; Cocarcinogenesis; Cyclophosphamide; Doxorubicin; Humans; Immunologic Deficiency Syndromes; Kidney Neoplasms; Kidney Pelvis; Lymphocyte Activation; Lymphoma, Non-Hodgkin; Male; Mitogens; Neoplasms, Second Primary; Prednisolone; Smoking; T-Lymphocytes; Vincristine; Vindesine | 1996 |
Non-Hodgkin's lymphoma followed by plasmacytoma, both arising in A thyroid gland with Hashimoto's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Cisplatin; Clone Cells; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Gene Rearrangement, B-Lymphocyte; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasms, Second Primary; Neoplastic Stem Cells; Plasmacytoma; Radiotherapy, Adjuvant; Remission Induction; Thyroid Neoplasms; Thyroidectomy; Thyroiditis, Autoimmune; Vindesine | 1999 |
Long-term outcome of low-grade oligodendroglioma and mixed glioma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Oligodendroglioma; Postoperative Complications; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Treatment Outcome; Vindesine | 2000 |
[Chemo-thermotherapy of radiation-induced squamous cell carcinoma in anterior chest wall].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy; Thoracic Neoplasms; Vindesine | 1992 |